Home Cart 0 Sign in  
X

[ CAS No. 150529-73-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 150529-73-0
Chemical Structure| 150529-73-0
Chemical Structure| 150529-73-0
Structure of 150529-73-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 150529-73-0 ]

Related Doc. of [ 150529-73-0 ]

Alternatived Products of [ 150529-73-0 ]

Product Details of [ 150529-73-0 ]

CAS No. :150529-73-0 MDL No. :MFCD06858764
Formula : C9H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ULSSGHADTSRELG-UHFFFAOYSA-N
M.W : 229.07 Pubchem ID :11746402
Synonyms :

Calculated chemistry of [ 150529-73-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.01
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.7
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 2.7
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.13
Solubility : 0.169 mg/ml ; 0.000736 mol/l
Class : Soluble
Log S (Ali) : -2.91
Solubility : 0.285 mg/ml ; 0.00124 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0419 mg/ml ; 0.000183 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.71

Safety of [ 150529-73-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 150529-73-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 150529-73-0 ]
  • Downstream synthetic route of [ 150529-73-0 ]

[ 150529-73-0 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 150529-73-0 ]
  • [ 2084-13-1 ]
Reference: [1] Patent: WO2013/52110, 2013, A1,
  • 2
  • [ 150529-73-0 ]
  • [ 28229-69-8 ]
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 42, p. 14737 - 14741
  • 3
  • [ 150529-73-0 ]
  • [ 52787-19-6 ]
Reference: [1] Patent: WO2013/52110, 2013, A1,
  • 4
  • [ 150529-73-0 ]
  • [ 74-88-4 ]
  • [ 80622-53-3 ]
YieldReaction ConditionsOperation in experiment
82.3%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -78℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 3 h; Inert atmosphere
To a dry 100 mL three-necked flask was added methyl 3-bromophenylacetate (4.58 g, 20 mmol, 1.0 eq) under N2.Add anhydrous tetrahydrofuran (30 mL),A 2.0 M solution of lithium diisopropylamide in THF / heptane / ethylbenzene (10.5 mL, 21 mmol, 1.05 eq) was slowly added dropwise at -78 °C.After the completion of the dropwise addition, the mixture was stirred for 30 minutes, and then methyl iodide (2.84 g, 20 mmol,1.0eq). Stirring was continued at room temperature for a further 3 hours.60 mL of water was added to the reaction flask, followed by extraction with 50 mL of dichloromethane, and the mixture was separated.The aqueous phase was extracted twice more with 30 mL of dichloromethane. Combine the organic phase,Wash twice with saturated saline solution,Drying with anhydrous sodium sulfate, concentration, and the residue was separated by column chromatography.Methyl 2-(3-bromophenyl)propanoate 3.95 g was obtained in a yield of 82.3percent.
Reference: [1] Patent: CN108794319, 2018, A, . Location in patent: Paragraph 0033-0035
[2] Green Chemistry, 2017, vol. 19, # 20, p. 4798 - 4803
[3] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 11, p. 3299 - 3311
  • 5
  • [ 67-56-1 ]
  • [ 150529-73-0 ]
  • [ 80622-53-3 ]
Reference: [1] Advanced Synthesis and Catalysis, 2016, vol. 358, # 21, p. 3373 - 3380
  • 6
  • [ 67-56-1 ]
  • [ 1878-67-7 ]
  • [ 150529-73-0 ]
YieldReaction ConditionsOperation in experiment
100% With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; To dichloromethane (580 ml) solution of 25 g (116 mmol) of 3-bromophenylacetic acid were added 9.4 ml (232 mmol) of methanol and 0.15 g (1.2 mmol) of 4-(dimethylamino)pyridine. After cooling with ice, 26.8 g (140 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride was added thereto, and the resulting mixture was stirred overnight with gradually warming up to room temperature. The reaction mixture was washed with hydrochloric acid, saturated sodium bicarbonate solution and brine, and then dried over anhydrous magnesium sulfate. After filtrating and concentrating under reduced pressure, 27.3 g (quantitative) of the entitled compound was obtained as a pale yellow oil.1H-NMR(CDCl3)δ: 3.60(2H, s), 3.70(3H, s), 7.16-7.23(2H, m), 7.39-7.45(2H, m).
100% Heating / reflux A mixture of 3-bromophenylacetic acid (5.29 g, 24.6 mmol) and concentrated sulfuric acid (100 μL) in anhydrous methanol (40 mL) was refluxed overnight and then concentrated in vacuo. The residue was partitioned between ethyl acetate and saturated sodium bicarbonate solution. The organic layer was washed with saturated sodium bicarbonate solution, saturated sodium chloride solution, dried (MgSO4) and concentrated in vacuo to give 121A (5.82 g, 100percent) as pale yellow oil. LC-MS m/z: 228.18 (M+H)+.
99% for 2 h; Reflux INTERMEDIATE 6(3-BromophenyDacetic acid methyl ester Acetyl chloride (0.5 niL) was added to MeOH (100 mL). 3-Bromophenylacetic acid (15 g, 69.8 mmol) was added, and the mixture refluxed for 2 h. The solvent was removed in vacuo and the residue partitioned between DCM and water (50 mL each). The aqueous phase was extracted with DCM (20 mL) and the combined organic phases were dried (MgSO4) and the solvent removed in vacuo to give the title compound (15.85 g, 99percent) as a colourless oil. δH (CDCl3) 7.44 (s, IH), 7.37-7.43 (m, IH), 7.15-7.24 (m, 2H), 3.70 (s, 3H), 3.59 (s, 2H).
98% Heating / reflux To a solution of 3-bromophenylacetic acid (1 g, 4.65 mmol) in 20 mL MeOH at 0° C. was added thionyl chloride (0.51 mL, 1.5 eq.) dropwise. The resulting solution was then refluxed overnight under N2. The reaction was cooled to rt and the solvent was removed in vacuo. The residue was taken up in EtOAc, washed with sat'd. NaHCO3 and brine, then dried over Na2SO4, filtered and evaporated to provide the methyl ester in 98percent yield. 1HNMR (300 MHz, CDCl3) δ 7.57 (d, 1H, J=12 Hz); 7.29 (2H, dd, J=2.5, 0.8 Hz); 7.16 (m, 1H); 3.81 (s, 2H); 3.72 (s, 3H).
98.7% for 2 h; Reflux Acetyl chloride (0.08 mL, 1.2 mmol, 0.5 equiv), and 2-(3-bromophenyl)acetic acid (0.5 g, 2.3 mmol, 1.0 equiv) were added to MeOH (10 mL) and the reaction mixture was refluxed for 2 h. After consumption of starting material, the reaction mixture was concentrated and extracted with DCM. The organics were combined and washed with brine and dried over Na2S04, filtered and concentrated in vacuum to give methyl 2-(3-bromophenyl)acetate as colorless oil (0.525 g, 98.7percent). LC-MS (ES) m/z = 229.0, 231.0 [M+H]+ . H NMR (400 MHz, DMSOd6) δ 3.61 (s, 3 H), 3.70 (s, 2 H), 7.26 - 7.30 (m, 2 H), 7.43 - 7.46 (m, 1 H), 7.48 (s, 1 H).
97% at 10 - 20℃; for 2 h; a) Synthesis of methyl(3-bromophenyl)acetate25.00 g of (3-bromophenyl)acetic acid are dissolved in 80 ml of methanol in a 100 ml flask provided with magnetic stirrer, condenser, thermometer, dropping funnel and gas-discharge tube, 13.22 ml of thionyl chloride are added dropwise at max. 10° C. with cooling and stirring, and the mixture is subsequently stirred at RT for a further 2 h. The reaction mixture is poured onto ice, rendered alkaline using conc. sodium hydroxide solution and extracted with MTB ether. The combined MTB ether phases are dried and filtered. The solvent is subsequently removed.Yield: 25.44 g=0.111 mol=97percent of methyl(3-bromophenyl)acetate; TLC: CH2Cl2=100; Rf about 0.9; HPLC: RT=2.43 min.
97% at 10 - 20℃; for 2 h; a)
Synthesis of methyl (3-bromophenyl)acetate
25.00 g of (3-bromophenyl)acetic acid are dissolved in 80 ml of methanol in a 100 ml flask provided with magnetic stirrer, condenser, thermometer, dropping funnel with gas-discharge tube, 13.22 ml of thionyl chloride are added dropwise with cooling and stirring at max.
10° C., and the mixture is subsequently stirred at RT for a further 2 h.
The reaction mixture is poured onto ice, rendered alkaline using concentrated sodium hydroxide solution and extracted with MTB ether.
The combined MTB ether phases are dried, filtered and stripped off to dryness.
Yield: 25.44 g=0.111 mol=97percent of methyl(3-bromophenyl)acetate;
TLC: CH2Cl2=100; Rf approx. 0.9
HPLC: RT=2.43 min.
96% With hydrogenchloride In water at 20 - 58℃; for 2 h; 3-BROMOPHENYLACETIC acid (10000 mg, 46. 50MMOL) was dissolved in methanol (200 mL) at room temperature and concentrated hydrochloric acid (4 mL) was added. The resulting solution was heated at 58°C for 2h then cooled to room temperature at which time the volatiles were removed in vacuo. The crude material was dissolved in ethyl acetate and the solution was carefully poured into a saturated aqueous sodium bicarbonate solution. The phases were separated and the combined organic extracts were dried over magnesium sulfate and concentrated under reduced pressure. The crude product was purified by MPLC (Biotage) with a gradient of 4 to 35percent ACOET/HEXANES to give (3-bromo-phenyl)-acetic acid methyl ester as a colorless oil (10250 mg, 96percent). GC- MS (MH+ 230 RT = 9.34 min).
96% at 0 - 25℃; for 5 h; Acetyl chloride (0 7ml, 9 3mmol) was added dropwise to a solution of (3-bromo-phenyl)-acetic acid (20 Og, 93mmol) in methanol (500ml) at 0°C The reaction was stirred for 5 hours, allowing the temperature to warm gradually to 25°C The solvent was removed in vacuo and the residual oil was re-dissolved in dichloromethane, dried over sodium sulfate and concentrated in vacuo to afford the title compound as a colourless oil in 96percent yield, 20 6g1H NMR (400MHz, CDCI3) δ 3 59 (s, 2H) 3 70 (s, 3H), 7 24-7 17 (m, 2H), 7 37-7 45 (m, 2H), LRMS ESI m/z 253 [M+Na]+
96% at 20℃; Intermediate 2. (3-Bromo-phenyl)-acetic acid methyl ester. <n="19"/>[0056] Step A: 3-Bτomophenyl acetic acid (1.17 g, 5.44 mmol) is dissolved inMeOH (15 tnL) containing catalytic amounts of thionyl chloride (0.2 tnL). The solution is stirred at room temperature overnight. The solvent is evaporated, the remainder is dissolved in DCM and washed with water and saturated aqueous NaHCO3- The organic layer is dried (MgSO4), filtered and concentrated to afford the methyl ester 16 (1.20 g, 5.28 mmol, 96percent) as an oil: 1H-NMR (400MHz, CDCl3) δ = 7.44 (s, IH), 7.40 (ddd, J = 2.0, 2.4, 6.8 Hz, IH), 7.20 (m, 2H), 3.70 (s, 3H), 3.59 (s, 2H). MS calcd. for C9Hi0BrO2 (M+H"1") 229.1, found 229.0.
95% Reflux 3-Bromophenylacetic acid (100 g, 0.47 mol) was dissolved in methanol (1000 ml) and concentrated sulfuric acid (1 ml) added and the mixture heated at reflux overnight.
The methanol was evaporated and the residue partitioned between dichloromethane (600 ml) and saturated aqueous sodium bicarbonate (200 ml).
The organic layer was washed with brine (300 ml), dried over magnesium sulfate and concentrated to give methyl 2-(3-bromophenyl)acetate (102 g, 0.45 mol, 95percent) as an oil.
1H NMR (400 MHz, CDCl3): δ ppm 7.43 (bt, 1H), 7.38 (dt, 1H), 7.15-7.19 (m, 2H), 3.68 (s, 3H), 3.58 (s, 2H)
95% for 5 h; Dean-Stark; Reflux 2- (3-bromophenyl) acetic acid (1.00 g, 4.65 mmol) was dissolved in freshly distilled methanol (50 ml.) . Added cone. H2S04 (8 drops) and refluxed in a Dean-Stark apparatus for 3 hrs. Reaction mixture was cooled to room temperature and concentrated in vacuo. The crude product was dissolved in CH2C12 (40 mL) and washed with sat. NaHC03 (30 mL x 2) and sat. NaCl (30 mL) . The organic layer was dried (anhydrous sodium sulfate) and concentrated in vacuo. The crude product was chromatographed on silica gel (Hexanes/EtOAc, 5:1) to yield target compound 73. Yield 1.011 g, 95percent. Rf = 0.60, H NMR (400 MHz, Chloroform-d) δ 7.47 - 7.43 (m, 1H) , 7.41 (dt, J = 6.5, 2.2 Hz, 1H) , 7.24 - 7.16 (m, 2H) , 3.70 (s, 3H) , 3.60 (s, 2H) ; [M+H]+ = 230.12 (APCI+) .
94% at 0 - 80℃; for 3 h; [0180] To a solution of 2-(3-bromophenyl)acetic acid (5.0 g, 23.3 mmol) in CH3OH (30 mL), was added SOCl2 (3.2 g, 27.0 mmol) at 0 °C. Then the mixture was stirred at 80 °C for 3 hours. The solvent was removed under reduced pressure to give methyl 2-(3- bromophenyl)acetate (5.0 g, yield: 94percent); LC/MS: m/z (M++l) = 231.
91% at 40℃; for 16 h; Example 18; Preparation of Methyl (3-Bromophenyl)acetateA stirred solution of (3-bromophenyl)acetic acid (10.0 g, 0.0465 mol) and concentrated sulfuric acid (4.5 mL) in MeOH (230 mL) was heated at 40 0C for 16 h. The reaction mixture was concentrated under reduced pressure and the residue was mixed with water (50 mL) and DCM (100 mL). The layers were separated and the organic layer was concentrated under reduced pressure. The residue was purified by silica gel flash chromatography (0-10percent EtOAc/hexanes) to give the title compound (19.8 g, 91 percent yield) as a colorless oil.LC-MS (Method 10-90): Rt 3.36 min; mlz 300.4 [M + H]+; 229.6 [M+]. 1H NMR (CD3OD) δ 7.48(s, IH); 7.44(d, IH); 7.26-7.25(m, 2H); 3.71(s, 3H); 3.66(s, 2H).
90% for 3 h; Reflux Step 1 : [00152] To a solution of (3-bromophenyl)acetic acid (12.2 g, 56.8 mmol) in methanol (150 ml_) was added p-toluenesulfonic acid (5.4 g, 28.4 mmol). The reaction mixture was stirred at reflux for 3 hours. The solvent was evaporated and the residue was dissolved in a mixture of ethyl acetate/water (3:2). The organic layer was dried over sodium sulfate and concentrated. The residue was purified using a silica pad eluting with a mixture of hexanes/ethyl acetate (9:1). This gave (3-bromophenyl)acetic acid methyl ester as a colorless oil (11.7 g, 90percent). 1H NMR (400 MHz, CD3OD): δ = 7.46 (m, 1 H), 7.41 (m, 1 H), 7.22 (m, 2H), 3.68 (s, 3H)1 3.65 (s, 2H); LRMS (ESI): m/z = 229 (MH+); HPLC: 3.8 min.
90% for 3 h; Reflux [0095] Step 1 : To a solution of (3-bromophenyl)acetic acid (12.2 g, 56.8 mmol) in methanol(150 mL) was added p-toluenesulfonic acid (5.4 g, 28.4 mmol). The reaction mixture was stirred at reflux for 3 h. The solvent was evaporated and the residue was dissolved in a mixture of ethyl acetate/water (3:2). The organic layer was dried over sodium sulfate and concentrated. The residue was purified using a silica pad eluting with a mixture of hexanes/ethyl acetate (9:1 ). This gave (3- bromophenyl)acetic acid methyl ester as a colorless oil (1 1.7 g, 90percent). 1H NMR (400 MHz, CD3OD): δ = 7.46 (m, 1 H), 7.41 (m, 1 H), 7.22 (m, 2H), 3.68 (s, 3H), 3.65 (s, 2H); LRMS (ESI): m/z = 229 (MH+); HPLC: 3.8 min.
86.1% Reflux Methyl 2-(3-bromophenyl) acetateBrTo the solution of the starting material (12.0 g, 55.8 mmol) in MeOH (200 mL) wasadded SOCI2(2 mL). The reaction solution was stirred and heated to reflux overnight.After the reaction was completed, 200mL of water and 30 mL of NaHCO3 aq. were added. The mixture was extracted with EA (150 mL x 3). The combined organic layers were washed with brine and dried over Na2504. After filtration and evaporation of the solvent, the product (11 .Og, 86.1 percent) was obtained.
86.1% Reflux To the solution of the starting material (12.0 g, 55.8 mmol) in MeOH (200 mL) was added SOCI2 (2 mL). The reaction solution was stirred and heated to reflux overnight. After the reaction was completed, 200mL of water and 30 mL of NaHCOs aq. were added. The mixture was extracted with EA (150 mL x 3). The combined organic layers were washed with brine and dried over Na2SO4. After filtration and evaporation of the solvent, the product (1 1 . Og, 86.1 percent) was obtained.
4.9 g With hydrogenchloride In water for 3 h; Reflux (3-Bromophenyl)acetic acid 11 (5.0 g, 23.3 mmol) and methanol (50 mL) were refluxed for 3 h in the presence of 0.2 mL of concentrated hydrochloric acid (HCl) to give the methyl (3-bromophenyl)acetate. After neutralization with saturated NaHCO3 and washing with brine, a pure product was obtained from the diethyl ether extract. This methyl acetate (4.9 g, 21.4 mmol) in dry THF (35 mL) was added dropwise to a stirred solution of 2.0 mol/L lithium diisopropylamide (LDA) (12.9 mL, 25.8 mmol) in THF/ethylbenzene/heptane at -78 °C under argon (Ar), and after 30 min, iodomethane (CH3I) (2.0 mL, 32.2 mmol) was added slowly. The resulting solution was stirred for 5 h with the temperature changed from -78 to -40 °C, then evaporated to dryness, and extracted with CH2Cl2 (50 mL). Evaporation of the solvent and purification of the residue by silica gel chromatography (n-hexane/AcOEt, 20:1) yielded the title compound as a colorless liquid (77.2percent). 1H NMR (CDCl3) δ: 1.49 (3H, d, J = 7.1 Hz, α-CH3), 3.67 (3H, s, CO2CH3), 3.68 (1H, q, J = 7.1 Hz, CH), 7.18 (1H, t, J = 7.5 Hz, Ar-H5), 7.23 (1H, dt, J = 7.8, 1.7 Hz, Ar-H6), 7.38 (1H, dt, J = 7.3, 1.8 Hz, Ar-H4), 7.44 (1H, st, J = 1.7 Hz, Ar-H2). FAB-MS (m/z): 243.02 (M++H, calcd for C10H1279BrO2: 243.00).
1.97 g at 0℃; for 2 h; Reflux Example 5A: Methyl 2-(3 -bromophenyl)acetate j00225j 3-Bromophenylacetic acid (2.0 g, 9.30 mmol) was dissolved in MeOH (46.5mL) and cooled to 0 °C. SOC12 (3.39 mL, 46.5 mmol) was added carefully dropwise.The reaction was then heated to reflux at for 2 h. The reaction was cooled to ambient temperature and concentrated in vacuo. The crude material was purified by silica gel chromatography (0 to 100percent EtOAc in hexanes to yield Example 5A (1 .97g, 8.60 mmol). 1H NMR (400 MHz, CHLOROFORM-cl) ö ppm 7.44 (1 H, s), 7.36 - 7.43 (1 H, m), 7.15 -7.24 (2 H, m), 3.70 (3 H, s), 3.60 (2 H, s).

Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 13, p. 2843 - 2866
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 3, p. 392 - 395
[3] Patent: EP1479681, 2004, A1, . Location in patent: Page 111; 112
[4] Patent: US2007/3539, 2007, A1, . Location in patent: Page/Page column 96
[5] Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 4976 - 4984
[6] Tetrahedron Letters, 2003, vol. 44, # 2, p. 331 - 334
[7] Journal of Organic Chemistry, 2005, vol. 70, # 18, p. 7305 - 7316
[8] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 4, p. 1679 - 1693
[9] Patent: WO2010/52448, 2010, A2, . Location in patent: Page/Page column 36
[10] Patent: US2004/220206, 2004, A1, . Location in patent: Page 29
[11] Patent: WO2015/136463, 2015, A1, . Location in patent: Page/Page column 123
[12] Patent: US2011/257172, 2011, A1, . Location in patent: Page/Page column 19
[13] Patent: US2011/257173, 2011, A1, . Location in patent: Page/Page column 19-20
[14] Patent: WO2005/14566, 2005, A1, . Location in patent: Page/Page column 83
[15] Patent: WO2006/51373, 2006, A1, . Location in patent: Page/Page column 46
[16] Patent: WO2007/89667, 2007, A1, . Location in patent: Page/Page column 17-18
[17] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
[18] Advanced Synthesis and Catalysis, 2012, vol. 354, # 4, p. 751 - 756
[19] Patent: US2010/197591, 2010, A1, . Location in patent: Page/Page column 15
[20] Patent: WO2013/52110, 2013, A1, . Location in patent: Page/Page column 63; 64
[21] Patent: WO2013/6792, 2013, A1, . Location in patent: Paragraph 0180
[22] European Journal of Organic Chemistry, 2002, # 23, p. 3966 - 3973
[23] Patent: WO2010/123766, 2010, A1, . Location in patent: Page/Page column 62
[24] Patent: WO2010/127440, 2010, A1, . Location in patent: Page/Page column 45
[25] Patent: WO2012/97427, 2012, A1, . Location in patent: Page/Page column 31-32
[26] Green Chemistry, 2017, vol. 19, # 20, p. 4798 - 4803
[27] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 15, p. 4694 - 4703
[28] Patent: WO2014/154727, 2014, A1, . Location in patent: Page/Page column 80
[29] Patent: WO2014/154726, 2014, A1, . Location in patent: Page/Page column 84
[30] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 16, p. 1893 - 1895
[31] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2647 - 2652
[32] Patent: EP1574501, 2005, A1, . Location in patent: Page/Page column 24
[33] Patent: WO2005/92840, 2005, A1, . Location in patent: Page/Page column 56-57
[34] Patent: US2005/222128, 2005, A1, . Location in patent: Page/Page column 28
[35] Patent: EP1577291, 2005, A1, . Location in patent: Page/Page column 67
[36] Patent: EP1577292, 2005, A1, . Location in patent: Page/Page column 34
[37] Patent: US2006/106107, 2006, A1, . Location in patent: Page/Page column 9
[38] Patent: US2006/149070, 2006, A1, . Location in patent: Page/Page column 37
[39] Patent: WO2007/87448, 2007, A1, . Location in patent: Page/Page column 34; 35
[40] Patent: WO2008/39882, 2008, A1, . Location in patent: Page/Page column 201
[41] Patent: US2009/197959, 2009, A1, . Location in patent: Page/Page column 17; 18
[42] Patent: WO2004/108675, 2004, A1, . Location in patent: Page 99; 100
[43] Patent: WO2005/92860, 2005, A1, . Location in patent: Page/Page column 52
[44] ACS Medicinal Chemistry Letters, 2010, vol. 1, # 4, p. 145 - 149
[45] Journal of Medicinal Chemistry, 2010, vol. 53, # 18, p. 6640 - 6652
[46] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 11, p. 3299 - 3311
[47] Patent: WO2014/201073, 2014, A1, . Location in patent: Paragraph 00225
[48] Russian Journal of Bioorganic Chemistry, 2015, vol. 41, # 2, p. 170 - 177
[49] Patent: WO2004/16601, 2004, A1, . Location in patent: Page 32
[50] Patent: WO2007/106016, 2007, A1, . Location in patent: Page/Page column 86
[51] Patent: WO2009/108720, 2009, A2, . Location in patent: Page/Page column 124
[52] Patent: WO2005/113519, 2005, A1, . Location in patent: Page/Page column 47-48
[53] Patent: WO2008/39882, 2008, A1, . Location in patent: Page/Page column 201
  • 7
  • [ 1878-67-7 ]
  • [ 150529-73-0 ]
YieldReaction ConditionsOperation in experiment
100% With sulfuric acid In methanol for 3 h; Heating / reflux Step (v); Methyl 3-bromophenylacetate; [Show Image] To 3-bromophenylacetic acid 10.0g (46.5mmol) were added methanol 150ml and sulfuric acid 5ml and the mixture was refluxed for 3 hours. After neutralization with aqueous ammonia and removal of the solvent by distillation, to the residue was added water and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, concentrated and the residue was purified by column chromatography (SiO2 200g, eluent: Hexane/EtOAc=6/ 1) to give the object compound 10.65g as a colorless oil. Quantitatively 1H NMR (CDCl3) δ 7.44 (1H, s), 7.41 (1H, m), 7.21 (2H, m), 3.71 (3H, s), 3.60 (2H, s).
99% With sulfuric acid In methanol; dichloromethane; ethyl acetate Part A
3-Bromophenyl acetic acid (2.0 g, 9.3 mmol) was dissolved in methanol (20 ml) in a 50 ml flask.
Concentrated sulfuric acid (2 drops) was added, and the mixture was refluxed under nitrogen for ten hours then concentrated under reduced pressure.
The residue was mixed with dichloromethane (20 ml) and saturated sodium bicarbonate solution (10 ml).
The organic material was separated, dried (MgSO4) and concentrated under reduced pressure.
The residue was flushed through silica gel with hexane/ethyl acetate (3:1), and concentrated to provide 2.12 g (99percent) of methyl (3-bromophenyl)acetate, which was used without further purification.
Reference: [1] Patent: EP1939202, 2008, A1, . Location in patent: Page/Page column 41
[2] Patent: US6518267, 2003, B1,
[3] Patent: US5444050, 1995, A,
[4] Patent: WO2006/44732, 2006, A2, . Location in patent: Page/Page column 202
[5] Patent: US2005/80111, 2005, A1,
[6] Angewandte Chemie - International Edition, 2012, vol. 51, # 2, p. 548 - 551
[7] Patent: WO2004/108676, 2004, A1, . Location in patent: Page 129-130
  • 8
  • [ 67-56-1 ]
  • [ 35065-86-2 ]
  • [ 150529-73-0 ]
YieldReaction ConditionsOperation in experiment
97% With sulfuric acid In water for 18 h; Reflux; Inert atmosphere General procedure: A stirred solution of the appropriate bromophenyl alkanoic acid(1 eq) in MeOH (25 mL)was treated with H2SO4 (0.1 eq of a conc. aq.solution) and heated at reflux for 18 h. The resultant solution wascooled to room temperature and concentrated under reducedpressure. The resultant oil was diluted with NaHCO3 (50 mL of a sat.aq. solution) and subsequently extracted with diethyl ether(3 25 mL). The combined organics were washed with brine(1 100 mL), dried (MgSO4), filtered and concentrated underreduced pressure to give the desired methyl ester:
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 143, p. 1644 - 1656
  • 9
  • [ 1878-67-7 ]
  • [ 18107-18-1 ]
  • [ 150529-73-0 ]
Reference: [1] Patent: US2003/171377, 2003, A1,
[2] Patent: US6939861, 2005, B2,
[3] Patent: US2003/199458, 2003, A1, . Location in patent: Page/Page column 48
  • 10
  • [ 1878-67-7 ]
  • [ 75-36-5 ]
  • [ 150529-73-0 ]
Reference: [1] Patent: EP1477167, 2004, A1, . Location in patent: Page/Page column 43
  • 11
  • [ 1878-67-7 ]
  • [ 74-88-4 ]
  • [ 150529-73-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2011, vol. 59, # 12, p. 1523 - 1534
  • 12
  • [ 18698-97-0 ]
  • [ 75-36-5 ]
  • [ 150529-73-0 ]
Reference: [1] Patent: US6034131, 2000, A,
  • 13
  • [ 186581-53-3 ]
  • [ 1878-67-7 ]
  • [ 150529-73-0 ]
Reference: [1] Patent: US2002/65230, 2002, A1,
[2] Patent: US5998470, 1999, A,
  • 14
  • [ 124-41-4 ]
  • [ 150529-73-0 ]
Reference: [1] Helvetica Chimica Acta, 1998, vol. 81, # 2, p. 251 - 267
  • 15
  • [ 67-56-1 ]
  • [ 1360789-08-7 ]
  • [ 150529-73-0 ]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 2, p. 548 - 551
  • 16
  • [ 150529-73-0 ]
  • [ 73183-34-3 ]
  • [ 478375-42-7 ]
YieldReaction ConditionsOperation in experiment
100% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 85℃; for 4 h; Inert atmosphere Step 1: Methyl 2-(3-(4,4,5,5-tetramethyl- 1 ,3,2-dioxaborolan-2-yl)phenyl)acetateA suspension of methyl 2-(3-bromophenyl)acetate (5.00 g, 21.8 mmol), bis(pinacolato)diboron (11.1 g, 43.7 mmol) and potassium acetate (6.43 g, 65.5 mmol) in dioxane (43.7 ml) was degassed with bubbling nitrogen. PdC12(dppf)-CH2C12 adduct (0.446 g, 0.546 mmol) was added, and the reaction was heated to 85 °C for 4 h. The reaction was diluted with ethyl acetate (30 mL) and filtered through Celite. The organiclayer was washed with brine, separated, and dried with sodium sulfate. The solvent was evaporated, and the residue was purified by column chromatography on silica gel (220 g column, gradient from 0percent to 40percent EtOAc/hexanes) to give the title compound (6.00 g, 100percent) as a colorless oil. ‘H NMR (400MHz, CDC13) ö 7.74 (s, 1H), 7.72 (s, 1H), 7.40 (t, J=1.7 Hz, 1H), 7.38-7.33 (m, 1H), 3.70 (s, 3H), 3.65 (s, 2H), 1.36 (s, 12H); LCMS(M+H) = 277.3; HPLC RT = 0.99 mm (Column: BEH C18 2.1 x 50 mm; Mobile Phase A: Water with 0.05percent TFA; Mobile Phase B: Acetonitrile with 0.05percent TFA; Gradient: 2- 98percent B over 1.6 mm; Flow: 0.8 mL/min).
100% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 85℃; for 4 h; Inert atmosphere A suspension of methyl 2-(3-bromophenyl)acetate (5.00 g, 21.8 mmol), bis(pinacolato)diboron (11.1 g, 43.7 mmol) and potassium acetate (6.43 g, 65.5 mmol) in dioxane (43.7 ml) was degassed with bubbling nitrogen. PdCl2(dppf)-CH2Cl2 adduct (0.446 g, 0.546 mmol) was added, and the reaction was heated to 85° C. for 4 h. The reaction was diluted with ethyl acetate (30 mL) and filtered through Celite. The organic layer was washed with brine, separated, and dried with sodium sulfate. The solvent was evaporated, and the residue was purified by column chromatography on silica gel (220 g column, gradient from 0percent to 40percent EtOAc/hexanes) to give the title compound (6.00 g, 100percent) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.74 (s, 1H), 7.72 (s, 1H), 7.40 (t, J=1.7 Hz, 1H), 7.38-7.33 (m, 1H), 3.70 (s, 3H), 3.65 (s, 2H), 1.36 (s, 12H); LCMS (M+H)=277.3; HPLC RT=0.99 min (Column: BEH C18 2.1×50 mm; Mobile Phase A: Water with 0.05percent TFA; Mobile Phase B: Acetonitrile with 0.05percent TFA; Gradient: 2-98percent B over 1.6 min; Flow: 0.8 mL/min).
73% With potassium acetate In N,N-dimethyl-formamide b) Synthesis of methyl[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-phenyl]acetate25.44 g of methyl(3-bromophenyl)acetate are dissolved in 200 ml of DMF in a 500 ml flask provided with stirrer, thermometer, condenser and drying tube, 42.30 g of 4,4,5,5,4',4',5',5'-octamethyl-[2,2]bi[1,3,2-dioxaborolanyl] and 32.70 g of potassium acetate are added, and the mixture is heated to 80° C. with stirring. 2.44 g of 1,1-bis(diphenylphosphino)ferrocenepalladium(II)dichloride are then added and stirred at 80° C. for 4 days. The mixture is poured onto about 300 ml of ice-water and extracted by shaking with 300 ml of MTB ether. Owing to poor separation, the mixture is filtered with suction, and the filtrate is again extracted by shaking with 300 ml of MTB ether. The solvent is then removed, and the residue is chromatographed over a silica-gel column.Yield: 21.00 g=76.05 mmol=73percent;TLC: CH2Cl2=100; Rf about 0.4;HPLC: RT=4.72 min.
73% With potassium acetate In N,N-dimethyl-formamide at 80℃; for 96 h; b)
Synthesis of methyl[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate
25.44 g of methyl (3-bromophenyl)acetate are dissolved in 200 ml of DMF in a 500 ml flask provided with precision glass stirrer, thermometer, condenser and drying tube, 42.30 g of 4,4,5,5,4',4',5',5'-octamethyl[2,2]bi[1,3,2-dioxaborolanyl] and 32.70 g of potassium acetate are added, and the mixture is heated to 80° C. with stirring.
2.44 g of 1,1-bis(diphenylphosphino)ferrocenepalladium(II) dichloride are then added, and the mixture is stirred at 80° C. for 4 days.
The mixture is poured onto about 300 ml of ice-water and extracted by shaking with 300 ml of MTB ether.
Owing to poor separation, the mixture is filtered with suction, and the filtrate is again extracted by shaking with 300 ml of MTB ether.

Reference: [1] Patent: WO2015/100282, 2015, A1, . Location in patent: Page/Page column 279
[2] Patent: US2016/176864, 2016, A1, . Location in patent: Paragraph 0792; 0793
[3] Journal of Medicinal Chemistry, 2007, vol. 50, # 6, p. 1101 - 1115
[4] Patent: US2011/257172, 2011, A1, . Location in patent: Page/Page column 19
[5] Patent: US2011/257173, 2011, A1, . Location in patent: Page/Page column 19-21
[6] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
[7] Journal of Medicinal Chemistry, 2016, vol. 59, # 23, p. 10479 - 10497
  • 17
  • [ 150529-73-0 ]
  • [ 478375-42-7 ]
Reference: [1] Patent: EP1394147, 2004, A1, . Location in patent: Page 143
  • 18
  • [ 150529-73-0 ]
  • [ 71420-95-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2647 - 2652
  • 19
  • [ 150529-73-0 ]
  • [ 74-88-4 ]
  • [ 251458-15-8 ]
YieldReaction ConditionsOperation in experiment
67%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 50℃; for 2 h; Inert atmosphere
Stage #2: at 20 - 40℃;
Sodium hydride (60percent in oil) (10.4 g, 436 mmol) was added to tetrahydrofuran (400 ml) under argon and heated with stirring to 50° C. Methyl 2-(3-bromophenyl)acetate (20 g, 87.3 mmol) was added drop wise over 30 minutes and heating continued for 90 minutes.
The temperature was lowered to below 40° C. and methyl iodide (13 ml, 209 mmol) was added over 10 minutes.
The resulting suspension was stirred at room temperature overnight.
Water (300 ml) was carefully added and reaction mixture concentrated.
Residue was partitioned between diethyl ether (400 ml) and water.
The aqueous layer was extracted with diethyl ether (400 ml), and the combined ethereal extracts were dried over sodium sulfate and concentrated.
Crude oil was purified by column chromatography, eluding with a gradient from 0percent to 20percent ethyl acetate in heptane to give methyl 2-(3-bromophenyl)-2-methylpropanoate (14.96 g, 58 mmol, 67percent).
1H NMR (400 MHz, CDCl3): δ ppm 7.47 (t, 1H), 7.37 (dt, 1H), 7.24 (dt, 1H), 7.18 (t, 1H), 3.65 (s, 3H), 1.55 (s, 6H)
51%
Stage #1: With sodium hydride In tetrahydrofuran for 0.25 h;
Stage #2: at 20℃;
Example 4A: methyl 2-(3-bromophenyl)-2-methylpropanoate j00218j Example 5A (154 mg, 0.672 mmol) was dissolved in THF (2.24 mL). Sodium hydride (46.8 mg, 1.95 mmol) was added and the reaction was stirred for 15 minutes.Methyl iodide (807 iL) was added and the reaction was allowed to stir overnight at ambient temperature. The reaction was quenched with water and extracted twice with EtOAc. The combined organic extracts were washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo. The crude material was purified by silica gel column chromatography (0 to 100percent EtOAc in hexanes) to yield Example 4A (87.5 mg, 51percent) as aclear oil. 1H NMR (400 MHz, CHLOROFORM-d) ö ppm 7.48 (1 H, t, J=1.88 Hz), 7.37 (1 H, dt, J=7.78, 1.51 Hz), 7.23 - 7.28 (1 H, m), 7.20 (1 H, d, J=7.78 Hz), 3.65 (3 H, s), 1.56(6 H, s).
Reference: [1] Patent: US2010/197591, 2010, A1, . Location in patent: Page/Page column 15-16
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 3, p. 392 - 395
[3] Patent: US2005/80111, 2005, A1,
[4] Patent: WO2014/201073, 2014, A1, . Location in patent: Paragraph 00218
[5] Patent: WO2004/48374, 2004, A1, . Location in patent: Page 47
[6] Patent: WO2010/52448, 2010, A2, . Location in patent: Page/Page column 36
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 150529-73-0 ]

Aryls

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.98

Chemical Structure| 14062-30-7

[ 14062-30-7 ]

Ethyl 2-(3-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-25-0

[ 14062-25-0 ]

Ethyl 2-(4-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 151583-29-8

[ 151583-29-8 ]

Methyl 3-(3-bromophenyl)propanoate

Similarity: 0.94

Chemical Structure| 80622-53-3

[ 80622-53-3 ]

Methyl 2-(3-bromophenyl)propanoate

Similarity: 0.92

Bromides

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.98

Chemical Structure| 14062-30-7

[ 14062-30-7 ]

Ethyl 2-(3-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-25-0

[ 14062-25-0 ]

Ethyl 2-(4-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 151583-29-8

[ 151583-29-8 ]

Methyl 3-(3-bromophenyl)propanoate

Similarity: 0.94

Chemical Structure| 80622-53-3

[ 80622-53-3 ]

Methyl 2-(3-bromophenyl)propanoate

Similarity: 0.92

Esters

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.98

Chemical Structure| 14062-30-7

[ 14062-30-7 ]

Ethyl 2-(3-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-25-0

[ 14062-25-0 ]

Ethyl 2-(4-bromophenyl)acetate

Similarity: 0.94

Chemical Structure| 151583-29-8

[ 151583-29-8 ]

Methyl 3-(3-bromophenyl)propanoate

Similarity: 0.94

Chemical Structure| 80622-53-3

[ 80622-53-3 ]

Methyl 2-(3-bromophenyl)propanoate

Similarity: 0.92